FDA Advisers Dismiss Safety Warnings, Back Four Peptide Treatments

A panel of outside advisers to the U.S. Food and Drug Administration (FDA) voted Thursday to let specialized pharmacies produce and sell four peptide treatments the agency banned three years ago.

The votes are nonbinding, but they amount to a rebuke of the FDA’s own scientists who said the drugs have not been studied enough to know w...

Frequent Marijuana Use Linked To Higher Stress Hormone Levels

Marijuana may help you unwind — but using it too often could have the opposite effect on your stress response.

Researchers say adults who use pot frequently wake up with higher levels of cortisol, also known as the "stress hormone."

The body releases cortisol when you're under pressure to help regulate blood pressure, blood sug...

Money Problems Might Make Your Brain Old Before Its Time, Study Suggests

Being cash-strapped certainly frays your nerves, but it might also accelerate brain aging, a new study says.

People who have persistent money struggles or low income as young adults tend to perform less well on cognitive tests by age 53, researchers reported July 23 in the journal Innovation in Aging.

Further, brain scans re...

Back Pain? Try Swimming, Study Says

Suffering from low back pain?

A few laps in the swimming pool might help, a new study says.

An eight-week swimming program significantly improved function and pain among a group of people with back problems, researchers reported recently in the British Journal of Sports Medicine.

“They improved by about 50% from ...

Ozempic Cuts Down Calorie Intake For At Least A Year, Even If Hunger Returns, Trial Finds

Worried that your Ozempic is becoming less effective over time?

Don’t worry — you’re still eating less, even if you are feeling a bit hungrier, a new study says.

People on semaglutide for weight loss continue to eat less even after they’ve taken the drug for more than a year, researchers report in the August i...

Black MS Patients Dying Younger Than White Ones, Study Finds

Black people with multiple sclerosis (MS) die from the disease at a younger age than white folks, a new study reports.

The death rate among Black patients with MS peaks between ages 65 and 74, while white patients are most likely to die between 75 and 84, researchers report in the September issue of the journal Neurology Open Access